Alterations in levels and ratios of n-3 and n-6 polyunsaturated fatty acids in the temporal cortex and liver of vervet monkeys from birth to early adulthood

Physiology and Behavior

Volumn 156, Issue , 2016, Pages 71-78

  Miller, Leslie R ^a   Jorgensen, Matthew J ^a   Kaplan, Jay R ^a   Seeds, Michael C ^a   Rahbar, Elaheh ^a   Morgan, Timothy M ^a   Welborn, Andrea ^a   Chilton, Sarah M ^a   Gillis, Julianne ^a   Hester, Austin ^a   Rukstalis, Mae ^a   Sergeant, Susan ^a   Chilton, Floyd H ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic acid; Brain; Docosahexaenoic acid; Omega 3 deficiency; Psychiatric and developmental disorders

Indexed keywords

ADRENIC ACID; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; BRAIN DEVELOPMENT; BRAIN TISSUE; CHLOROCEBUS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DIET; FEMALE; GRAY MATTER; GROUPS BY AGE; LIPID ANALYSIS; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PUBERTY; TEMPORAL CORTEX; TEMPORAL LOBE; ANIMAL; CHLOROCEBUS AETHIOPS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; SEXUAL MATURATION;

ANIMALS; ARACHIDONIC ACID; CERCOPITHECUS AETHIOPS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, OMEGA-6; FEMALE; LIVER; MALE; SEXUAL MATURATION; TEMPORAL LOBE;

EID: 84954211096     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2015.12.009     Document Type: Article

References (59)

1. Gibson R.A., Muhlhausler B., Makrides M. Conversion of linoleic acid and alpha-linolenic acid to long-chain polyunsaturated fatty acids (LCPUFAs), with a focus on pregnancy, lactation and the first 2years of life. Matern. Child Nutr. 2011, 7(Suppl. 2):17-26.
2. Uauy R., Dangour A.D. Nutrition in brain development and aging: role of essential fatty acids. Nutr. Rev. 2006, 64:S24-S33.
3. Neuringer M., Anderson G.J., Connor W.E. The essentiality of n-3 fatty acids for the development and function of the retina and brain. Annu. Rev. Nutr. 1988, 8:517-541.
4. Neuringer M., Connor W.E., Lin D.S., Barstad L., Luck S. Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:4021-4025.
5. Novak E.M., Dyer R.A., Innis S.M. High dietary omega-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res. 2008, 1237:136-145.
6. Kuipers R.S., Luxwolda M.F., Offringa P.J., Boersma E.R., Dijck-Brouwer D.A., Muskiet F.A. Fetal intrauterine whole body linoleic, arachidonic and docosahexaenoic acid contents and accretion rates. Prostaglandins Leukot. Essent. Fat. Acids 2012, 86:13-20.
7. Gow R.V., Hibbeln J.R. Omega-3 fatty acid and nutrient deficits in adverse neurodevelopment and childhood behaviors. Child Adolesc. Psychiatr. Clin. N. Am. 2014, 23:555-590.
8. Bourre J.M. Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing. J. Nutr. Health Aging 2004, 8:163-174.
9. van Elst K., Bruining H., Birtoli B., Terreaux C., Buitelaar J.K., Kas M.J. Food for thought: dietary changes in essential fatty acid ratios and the increase in autism spectrum disorders. Neurosci. Biobehav. Rev. 2014, 45:369-378.
10. James S., Montgomery P., Williams K. Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst. Rev. 2011.
11. Gow R.V., Sumich A., Vallee-Tourangeau F., Angus C.M., Ghebremeskel K., Bueno A.A., et al. Omega-3 fatty acids are related to abnormal emotion processing in adolescent boys with attention deficit hyperactivity disorder. Prostaglandins Leukot. Essent. Fat. Acids 2013, 88:419-429.
12. Bondi C.O., Taha A.Y., Tock J.L., Totah N.K., Cheon Y., Torres G.E., et al. Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency. Biol. Psychiatry 2014, 75:38-46.
13. Kim S.W., Schafer M.R., Klier C.M., Berk M., Rice S., Allott K., et al. Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis. Schizophr. Res. 2014, 158:39-44.
14. Meyer B.J., Grenyer B.F., Crowe T., Owen A.J., Grigonis-Deane E.M., Howe P.R. Improvement of major depression is associated with increased erythrocyte DHA. Lipids 2013, 48:863-868.
15. Gillies D., Sinn J., Lad S.S., Leach M.J., Ross M.J. Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst. Rev. 2012, 7.
16. Rogers L.K., Valentine C.J., Keim S.A. DHA supplementation: current implications in pregnancy and childhood. Pharmacol. Res. 2013, 70:13-19.
17. Lattka E., Klopp N., Demmelmair H., Klingler M., Heinrich J., Koletzko B. Genetic variations in polyunsaturated fatty acid metabolism-implications for child health?. Ann. Nutr. Metab. 2012, 60(Suppl. 3):8-17.
18. Standl M., Lattka E., Stach B., Koletzko S., Bauer C.P., von Berg A., et al. FADS1 FADS2 gene cluster, PUFA intake and blood lipids in children: results from the GINIplus and LISAplus studies. PLoS One 2012, 7.
19. Horrobin D.F., Manku M.S., Hillman H., Iain A., Glen M. Fatty acid levels in the brains of schizophrenics and normal controls. Biol. Psychiatry 1991, 30:795-805.
20. Assies J., Lieverse R., Vreken P., Wanders R.J., Dingemans P.M., Linszen D.H. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol. Psychiatry 2001, 49:510-522.
21. Lin P.Y., Huang S.Y., Su K.P. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol. Psychiatry 2010, 68:140-147.
22. McNamara R.K., Hahn C.G., Jandacek R., Rider T., Tso P., Stanford K.E., et al. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol. Psychiatry 2007, 62:17-24.
23. Stevens L.J., Zentall S.S., Deck J.L., Abate M.L., Watkins B.A., Lipp S.R., et al. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder. Am. J. Clin. Nutr. 1995, 62:761-768.
24. Hawkey E., Nigg J.T. Omega-3 fatty acid and ADHD: blood level analysis and meta-analytic extension of supplementation trials. Clin. Psychol. Rev. 2014, 34:496-505.
25. McNamara R.K., Vannest J.J., Valentine C.J. Role of perinatal long-chain omega-3 fatty acids in cortical circuit maturation: Mechanisms and implications for psychopathology. World J. Psychiatry 2015, 5:15-34.
26. Martinez M., Mougan I. Fatty acid composition of human brain phospholipids during normal development. J. Neurochem. 1998, 71:2528-2533.
27. Carver J.D., Benford V.J., Han B., Cantor A.B. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res. Bull. 2001, 56:79-85.
28. Sprecher H. Biochemistry of essential fatty acids. Prog. Lipid Res. 1981, 20:13-22.
29. Park H.G., Park W.J., Kothapalli K.S., Brenna J.T. The fatty acid desaturase 2 (FADS2) gene product catalyzes Delta4 desaturation to yield n-3 docosahexaenoic acid and n-6 docosapentaenoic acid in human cells. FASEB J. 2015.
30. Kitson A.P., Smith T.L., Marks K.A., Stark K.D. Tissue-specific sex differences in docosahexaenoic acid and Delta6-desaturase in rats fed a standard chow diet. Appl. Physiol. Nutr. Metab. 2012, 37:1200-1211.
31. Mitchell R.W., Hatch G.M. Fatty acid transport into the brain: of fatty acid fables and lipid tails. Prostaglandins Leukot. Essent. Fat. Acids 2011, 85:293-302.
32. Kitson A.P., Stark K.D., Duncan R.E. Enzymes in brain phospholipid docosahexaenoic acid accretion: a PL-ethora of potential PL-ayers. Prostaglandins Leukot. Essent. Fat. Acids 2012, 87:1-10.
33. Bernoud N., Fenart L., Moliere P., Dehouck M.P., Lagarde M., Cecchelli R., et al. Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J. Neurochem. 1999, 72:338-345.
34. Nguyen L.N., Ma D., Shui G., Wong P., Cazenave-Gassiot A., Zhang X., et al. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature 2014, 509:503-506.
35. Hachem M., Geloen A., Van A.L., Foumaux B., Fenart L., Gosselet F., et al. Efficient docosahexaenoic acid uptake by the brain from a structured phospholipid. Mol. Neurobiol. 2015.
36. Bazinet R.P., Laye S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat. Rev. Neurosci. 2014, 15:771-785.
37. Kaduce T.L., Chen Y., Hell J.W., Spector A.A. Docosahexaenoic acid synthesis from n-3 fatty acid precursors in rat hippocampal neurons. J. Neurochem. 2008, 105:1525-1535.
38. Naughton J.M. Supply of polyenoic fatty acids to the mammalian brain: the ease of conversion of the short-chain essential fatty acids to their longer chain polyunsaturated metabolites in liver, brain, placenta and blood. Int. J. Biochem. 1981, 13:21-32.
39. Kavanagh K., Fairbanks L.A., Bailey J.N., Jorgensen M.J., Wilson M., Zhang L., et al. Characterization and heritability of obesity and associated risk factors in vervet monkeys. Obesity 2007, 15:1666-1674.
40. Metcalfe L.D., Schmitz A.A. Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis. Anal. Chem. 1966, 38:514-515.
41. Weaver K.L., Ivester P., Seeds M.C., Case L.D., Arm J., Chilton F.H. Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J. Biol. Chem. 2009, 284:15400-15407.
42. Bradbury J. Docosahexaenoic acid (DHA): an ancient nutrient for the modern human brain. Nutrients 2011, 3:529-554.
43. Chilton F.H., Murphy R.C., Wilson B.A., Sergeant S., Ainsworth H., Seeds M.C., et al. Diet-gene interactions and pufa metabolism: a potential contributor to health disparities and human diseases. Nutrients 2014, 6:1993-2022.
44. Green P., Yavin E. Mechanisms of docosahexaenoic acid accretion in the fetal brain. J. Neurosci. Res. 1998, 52:129-136.
45. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum. Dev. 1979, 3:79-83.
46. Jasinska A.J., Schmitt C.A., Service S.K., Cantor R.M., Dewar K., Jentsch J.D., et al. Systems biology of the vervet monkey. ILAR J. 2013, 54:122-143.
47. Diau G.Y., Hsieh A.T., Sarkadi-Nagy E.A., Wijendran V., Nathanielsz P.W., Brenna J.T. The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system. BMC Med. 2005, 3:11.
48. Amminger G.P., Schafer M.R., Papageorgiou K., Klier C.M., Cotton S.M., Harrigan S.M., et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch. Gen. Psychiatry 2010, 67:146-154.
49. Nemets H., Nemets B., Apter A., Bracha Z., Belmaker R.H. Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. Am. J. Psychiatry 2006, 163:1098-1100.
50. Bloch M.H., Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J. Am. Acad. Child Adolesc. Psychiatry 2011, 50:991-1000.
51. Sonuga-Barke E.J., Brandeis D., Cortese S., Daley D., Ferrin M., Holtmann M., et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am. J. Psychiatry 2013, 170:275-289.
52. McNamara R.K., Carlson S.E. Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology. Prostaglandins Leukot. Essent. Fat. Acids 2006, 75:329-349.
53. Carlson S.E. Docosahexaenoic acid and arachidonic acid in infant development. Semin. Neonatol. 2001, 6:437-449.
54. Levant B., Radel J.D., Carlson S.E. Decreased brain docosahexaenoic acid during development alters dopamine-related behaviors in adult rats that are differentially affected by dietary remediation. Behav. Brain Res. 2004, 152:49-57.
55. Sublette M.E., Galfalvy H.C., Hibbeln J.R., Keilp J.G., Malone K.M., Oquendo M.A., et al. Polyunsaturated fatty acid associations with dopaminergic indices in major depressive disorder. Int. J. Neuropsychopharmacol. 2014, 17:383-391.
56. Paus T. How environment and genes shape the adolescent brain. Horm. Behav. 2013, 64:195-202.
57. McNamara R.K., Sullivan J., Richtand N.M., Jandacek R., Rider T., Tso P., et al. Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult DBA/2J mice: relationship with ventral striatum dopamine concentrations. Synapse 2008, 62:725-735.
58. Hibbeln J.R., Nieminen L.R., Blasbalg T.L., Riggs J.A., Lands W.E. Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am. J. Clin. Nutr. 2006, 83:1483S-1493S.
59. Blasbalg T.L., Hibbeln J.R., Ramsden C.E., Majchrzak S.F., Rawlings R.R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am. J. Clin. Nutr. 2011, 93:950-962.